Abstract

Fourteen triterpene acids, viz., three tirucallane-type (1–3), eight ursane-type (4–11), two oleanane-type (12, 13) and one lupane type (21), along with boswellic aldehyde (14), α-amyrine (15), epi-amyrine (16), straight chain acid (17), sesquiterpene (19) and two cembrane-type diterpenes (18, 20) were isolated, first time, from the methanol extract of Boswellia elongata resin. Compound (1) was isolated for first time as a natural product, while the remaining compounds (2‒21) were reported for first time from B. elongata. The structures of all compounds were confirmed by advanced spectroscopic techniques including mass spectrometry and also by comparison with the reported literature. Eight compounds (1–5, 11, 19 and 20) were further screened for in vitro α-glucosidase inhibitory activity. Compounds 3–5 and 11 showed significant activity against α-glucosidase with IC50 values ranging from 9.9–56.8 μM. Compound 4 (IC50 = 9.9 ± 0.48 μM) demonstrated higher inhibition followed by 11 (IC50 = 14.9 ± 1.31 μM), 5 (IC50 = 20.9 ± 0.05 μM) and 3 (IC50 = 56.8 ± 1.30 μM), indicating that carboxylic acid play a key role in α-glucosidase inhibition. Kinetics studies on the active compounds 3–5 and 11 were carried out to investigate their mechanism (mode of inhibition and dissociation constants Ki). All compounds were found to be non-competitive inhibitors with Ki values in the range of 7.05 ± 0.17–51.15 ± 0.25 µM. Moreover, in silico docking was performed to search the allosteric hotspot for ligand binding which is targeted by our active compounds investigates the binding mode of active compounds and it was identified that compounds preferentially bind in the allosteric binding sites of α-glucosidase. The results obtained from docking study suggested that the carboxylic group is responsible for their biologic activities. Furthermore, the α-glucosidase inhibitory potential of the active compounds is reported here for the first time.

Highlights

  • Diabetes mellitus (DM)—mostly characterized by high blood-glucose levels, and their complications—increases the morbidity and mortality threats for type-2 diabetes patients [1,2]

  • (12.0, 4.8 Hz) of the β-oriented proton which appeared at δH 4.49, an interpretation and β-orientation further substantiated by heteronuclear multiple bond correlation (HMBC) correlation between H-5 and C-3 and nuclear overhauser effect spectroscopy (NEOSY) correlation between H-3 and CH3-23 position

  • It was shown that oleanolic acid binds at allosteric site (AS)-1 which is created by Trp14, Lys12, Ser295, Ala289, His258, Tyr292, Lys262, Val265, Ile271 and Glu270 while ursolic acid binds at AS-4 (Gln66, Gln67, Met69, Ser179, Arg180, Glu405, Val407, Lys410, Asn411, Trp465) [27] demonstrated that a mixed type inhibitor ((E)-3-butylideneisobenzofuran-1(3H)-one) binds to a site close to the catalytic site and is formed by residues Thr287, Val297, Ser299, His302, Ile334, Trp340, Ala341, Thr342 and Tyr344

Read more

Summary

Introduction

Diabetes mellitus (DM)—mostly characterized by high blood-glucose levels (hyperglycemia), and their complications—increases the morbidity and mortality threats for type-2 diabetes patients [1,2]. Α-Glucosidase inhibitors (AGIs) have inadequate protection, temporally recover the blood glucose levels, and improve Type-2 DM complications, together with the treatment of obesity [6,7] but accomplished with gastrointestinal side-effects like diarrhea, flatulence and abdominal discomfort [8,9,10]. Interesting previously isolated boswellic acids (BAs), bioactive components of frankincense, from the resins of Boswellia sacra and B. papyrifera demonstrated promising α-glucosidase activity [11]. BAs (bioactive components of frankincense) are mostly isolated from the resins of Boswellia species and considered to have interesting pharmacological, biologic and medicinal applications against chronic colitis, asthma, inflammation, arthritis, stomach ache, ulcerative colitis and hepatitis [17,18,19]. Previous report on the analgesic and anti-inflammatory activities of methanolic extract further supported the traditional application of this plant in treating various diseases associated with inflammation and pain [13]. No report is available on the phytochemical investigations of the title resin

General
Plant Material and Identification
Extraction and Isolation
Computational Modeling and Molecular Docking
Structural Elucidation of Compound 1
Kinetics Studies
Molecular Docking of α-Glucosidase Inhibitors
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call